Retour
37
Fourchette du Jour
97,11 €
103,85 €
Fourchette 52 Semaines
66,57 €
211,00 €
Volume
546 287
Moyenne 50J / 200J
136,39 €
/
161,56 €
Clôture Précédente
101,28 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 9,7 | 0,2 |
| P/B | 0,8 | 3,0 |
| ROE % | 8,4 | 3,6 |
| Net Margin % | 9,6 | 3,8 |
| Rev Growth 5Y % | 31,2 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Hold
157,44 €
+57.5%
Low: 100,00 €
High: 222,00 €
P/E Prévisionnel
7,98
BPA Prévisionnel
12,53 €
Croissance BPA (est.)
+0,0%
CA Est.
7,95B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
15,69 €
15,06 € – 16,00 €
|
8,94B | 1 |
| FY2028 |
14,98 €
10,44 € – 18,43 €
|
8,71B | 5 |
| FY2027 |
13,57 €
9,69 € – 16,94 €
|
8,27B | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-10-22 | 3,28 € | 3,31 € | +0,9% |
| 2025-07-23 | 3,19 € | 3,26 € | +2,2% |
| 2025-04-30 | 3,11 € | 3,19 € | +2,6% |
| 2025-02-19 | 3,41 € | 3,43 € | +0,6% |
| 2024-10-23 | 3,85 € | 3,35 € | -13,0% |
| 2024-07-24 | 3,68 € | 3,75 € | +1,9% |
| 2024-04-24 | 3,41 € | 3,47 € | +1,8% |
| 2024-02-21 | 3,44 € | 3,46 € | +0,6% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 31,17% annually over 5 years — strong growth
Earnings grew 29,26% over the past year
Debt/Equity of 0,38 — conservative balance sheet
Generating 1,12B in free cash flow
P/E of 9,65 — trading at a low valuation
PEG of 0,76 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
31,17%
Revenue (1Y)1,99%
Earnings (1Y)29,26%
FCF Growth (3Y)62,97%
Qualité
Return on Equity
8,44%
ROIC6,27%
Net Margin9,56%
Op. Margin13,26%
Sécurité
Debt / Equity
0,38
Current Ratio1,26
Interest Coverage4,63
Valorisation
P/E Ratio
9,65
Forward P/E7,98
P/B Ratio0,80
EV/EBITDA9,75
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,99% | Revenue Growth (3Y) | 3,43% |
| Earnings Growth (1Y) | 29,26% | Earnings Growth (3Y) | 25,15% |
| Revenue Growth (5Y) | 31,17% | Earnings Growth (5Y) | 24,65% |
| Profitability | |||
| Revenue (TTM) | 8,28B | Net Income (TTM) | 791,47M |
| ROE | 8,44% | ROA | 4,69% |
| Gross Margin | 29,42% | Operating Margin | 13,26% |
| Net Margin | 9,56% | Free Cash Flow (TTM) | 1,12B |
| ROIC | 6,27% | FCF Growth (3Y) | 62,97% |
| Safety | |||
| Debt / Equity | 0,38 | Current Ratio | 1,26 |
| Interest Coverage | 4,63 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 9,65 | Forward P/E | 7,98 |
| P/B Ratio | 0,80 | P/S Ratio | 0,92 |
| PEG Ratio | 0,76 | Forward PEG | N/A |
| EV/EBITDA | 9,75 | Fwd EV/EBITDA | 5,92 |
| Forward P/S | 0,96 | Fwd Earnings Yield | 12,53% |
| FCF Yield | 14,65% | ||
| Market Cap | 7,64B | Enterprise Value | 10,70B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 8,28B | 8,12B | 7,74B | 5,48B | 2,80B |
| Net Income | 791,47M | 612,34M | 505,30M | 153,19M | 327,81M |
| EPS (Diluted) | 9,53 | 7,40 | 6,13 | 2,25 | 6,24 |
| Gross Profit | 2,44B | 2,40B | 2,21B | 1,51B | 808,03M |
| Operating Income | 1,10B | 956,15M | 795,24M | 378,53M | 391,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 16,88B | 16,99B | 17,19B | 17,39B | 3,44B |
| Total Liabilities | 7,35B | 7,75B | 8,69B | 9,32B | 1,59B |
| Shareholders' Equity | 9,52B | 9,24B | 8,50B | 8,07B | 1,85B |
| Total Debt | 3,60B | 3,94B | 4,83B | 5,65B | 433,61M |
| Cash & Equivalents | 538,79M | 378,10M | 288,77M | 752,21M | 840,31M |
| Current Assets | 3,53B | 3,41B | 3,23B | 2,94B | 2,10B |
| Current Liabilities | 2,80B | 2,83B | 2,69B | 2,48B | 1,12B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#491 of 826
Activité Récente
Sorti
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026